Moingeon P - Search Results

1

Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.

Baron-Bodo V, Batard T, Nguyen H, Fréreux M, Horiot S, Harwanegg C, Bergmann KC, de Beaumont O, Moingeon P. Baron-Bodo V, et al. Among authors: moingeon p. Clin Exp Allergy. 2012 Oct;42(10):1510-8. doi: 10.1111/j.1365-2222.2012.04044.x. Clin Exp Allergy. 2012. PMID: 22994348 Clinical Trial.

2

Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy.

Batard T, Didierlaurent A, Chabre H, Mothes N, Bussières L, Bohle B, Couret MN, Ball T, Lemoine P, Focks Tejkl M, Chenal A, Clément G, Dupont F, Valent P, Krauth MT, André C, Valenta R, Moingeon P. Batard T, et al. Among authors: moingeon p. Int Arch Allergy Immunol. 2005 Mar;136(3):239-49. doi: 10.1159/000083950. Epub 2005 Feb 16. Int Arch Allergy Immunol. 2005. PMID: 15722633

3

Immune mechanisms of allergen-specific sublingual immunotherapy.

Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L. Moingeon P, et al. Allergy. 2006 Feb;61(2):151-65. doi: 10.1111/j.1398-9995.2006.01002.x. Allergy. 2006. PMID: 16409190 Review.

4

Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.

Mascarell L, Van Overtvelt L, Moingeon P. Mascarell L, et al. Among authors: moingeon p. Immunol Allergy Clin North Am. 2006 May;26(2):283-306, vii-viii. doi: 10.1016/j.iac.2006.02.009. Immunol Allergy Clin North Am. 2006. PMID: 16701145 Review.

5

Production and proteomic characterization of pharmaceutical-grade Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts for allergy vaccines.

Batard T, Hrabina A, Bi XZ, Chabre H, Lemoine P, Couret MN, Faccenda D, Villet B, Harzic P, André F, Goh SY, André C, Chew FT, Moingeon P. Batard T, et al. Among authors: moingeon p. Int Arch Allergy Immunol. 2006;140(4):295-305. doi: 10.1159/000093707. Epub 2006 Jun 1. Int Arch Allergy Immunol. 2006. PMID: 16741365

6

Sublingual immunotherapy: from biological extracts to recombinant allergens.

Moingeon P. Moingeon P. Allergy. 2006;61 Suppl 81:15-9. doi: 10.1111/j.1398-9995.2006.01157.x. Allergy. 2006. PMID: 16792601 Review.

7

Standardization of an ash (Fraxinus excelsior) pollen allergen extract.

Hrabina M, Purohit A, Oster JP, Papanikolaou I, Jain K, Pascal P, Sicard H, Gouyon B, Moingeon P, Pauli G, André C. Hrabina M, et al. Among authors: moingeon p. Int Arch Allergy Immunol. 2007;142(1):11-8. doi: 10.1159/000095994. Epub 2006 Sep 29. Int Arch Allergy Immunol. 2007. PMID: 17016054

8

Sublingual vaccines based on wild-type recombinant allergens.

Van Overtvelt L, Razafindratsita A, St-Lu N, Didierlaurent A, Batard T, Lombardi V, Martin E, Moingeon P. Van Overtvelt L, et al. Among authors: moingeon p. Eur Ann Allergy Clin Immunol. 2006 Sep;38(7):247-9. Eur Ann Allergy Clin Immunol. 2006. PMID: 17124785

9

Mucosal immunization application to allergic disease: sublingual immunotherapy.

Frati F, Moingeon P, Marcucci F, Puccinelli P, Sensi L, Di Cara G, Incorvaia C. Frati F, et al. Among authors: moingeon p. Allergy Asthma Proc. 2007 Jan-Feb;28(1):35-9. doi: 10.2500/aap.2007.28.2919. Allergy Asthma Proc. 2007. PMID: 17390755 Review.

10

Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.

Razafindratsita A, Saint-Lu N, Mascarell L, Berjont N, Bardon T, Betbeder D, Van Overtvelt L, Moingeon P. Razafindratsita A, et al. Among authors: moingeon p. J Allergy Clin Immunol. 2007 Aug;120(2):278-85. doi: 10.1016/j.jaci.2007.04.009. Epub 2007 May 25. J Allergy Clin Immunol. 2007. PMID: 17531296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters